Your breath can reveal more than just your oral hygiene habits. If you notice a fruity or acetone-like smell, it could signal ...

About Chiesi Group Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty ...

Structure Therapeutics shares surged over 50% on positive GSBR-1290 data, competing with other oral GLP-1R rivals. Find out ...

Sugary Beverages Linked to disruption in salivary microbiome: StudyA recent study published in the journal Scientific Reports ...

The University of Copenhagen is excited to announce BioVie as a Tier 2 Sponsor of the 11th Aging Research & Drug Discovery ...

It also increases insulin release from the pancreas and controls the feeling of satiety after eating. 1 Insulin is a hormone produced by the pancreas that regulates the amount of glucose in the blood.

The funding is part of Project NextGen, a $5 billion initiative led by the Biomedical Advanced Research and Development Authority (BARDA), to advance a pipeline of new, innovative vaccines and ...

The number of Americans with type 2 diabetes and/or obesity is rising, and the entry of therapies such as glucagon-like ...

A recent breakthrough in diabetes treatment- a cell therapy that cured a patient's diabetes, eliminating the need for insulin ...

Company expects to report top-line data and complete study results in Q3 2024 TORONTO, ONTARIO, June 13, 2024 (GLOBE NEWSWIRE ...

“The prevalence of type-2 diabetes continues to rise in children and adolescents, yet oral treatment options have remained ...

AstraZeneca’s FARXIGA® (dapagliflozin) has been approved by the US Food and Drug Administration (FDA) to improve glycemic control in pediatric patients with type-2 diabetes (T2D) aged 10 years and ...